Calendrier des promotions ARCA biopharma, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise ARCA biopharma, Inc.
ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.Paramètres de base
IPO date
1997-08-08
ISIN
US00211Y5069
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
66.25
Дивиденд ао
20.67
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 0 | 0 |
P/BV | 0.6659 | 10 |
P/E | 0 | 0 |
Efficacité
Nom | Signification | Grade |
ROA | -14.1 | 0 |
ROE | -14.42 | 0 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 66.25 | 10 |
DSI | 1 | 10 |
Croissance moyenne du dividende | 99.38 | 10 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | -0.0384 | 10 |
Debt/Ratio | 0.0074 | 10 |
Debt/Equity | 0.0227 | 10 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | 7721.03 | 10 |
Rentabilité Ebitda, % | 30.29 | 5 |
Rentabilité EPS, % | -91.08 | 0 |
Dividendes
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 2.4 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 2.4 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.30d | 2.4 $ | 2.4 $ | 2.4 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.90d | 2.4 $ | 2.4 $ | 2.4 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.180d | 2.4 $ | 2.4 $ | 2.4 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.1y | 3.81 $ | 2.4 $ | 4.16 $ | -37.01 % | 0 % | 0 % |
common.calendar.number_days.3y | 2.34 $ | 1.58 $ | 4.16 $ | 2.56 % | 0 % | 0 % |
common.calendar.number_days.5y | 7 $ | 1.58 $ | 7.99 $ | -65.71 % | 0 % | 0 % |
common.calendar.number_days.10y | 0.28 $ | 0.28 $ | 19.21 $ | 857.14 % | 0 % | 0 % |
common.calendar.number_days.ytd | 2.4 $ | 2.4 $ | 2.4 $ | 0 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Mr. Thomas A. Keuer | President, COO & Principal Executive Officer | 400.8k | 1959 (66 années) |
Mr. C. Jeffrey Dekker CPA | CFO, Treasurer & Company Secretary | 323.07k | 1965 (60 années) |
Informations sur l'entreprise
Adresse: United States, Westminster. CO, 10170 Church Ranch Way - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.arcabio.com
Site web: https://www.arcabio.com